Lightnews — Scholar-powered news

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Platinum Level supporters of the 2025 International Congress: Acadia Pharmaceuticals Inc., AskBio Inc., Biogen, H Lundbeck A/S, Medtronic, Merz Theraputics GmbH, and Supernus Pharmaceuticals. #MDSCongress

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 7d

MDS wishes to acknowledge the following Diamond Level supporters of the 2025 International Congress: Amneal Pharmaceuticals and Abbvie. #MDSCongress

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 8d

Gain essential skills for both clinical practice and research: emerging therapies, advanced techniques, and refined diagnostic strategies that integrate test analysis with thorough clinical evaluation. https://loom.ly/2EcHutA

2

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 9d

New consensus report on dystonia: Updated definition & classification with added clinical features, clarifications, and emphasis on biological heterogeneity. https://loom.ly/-jglkDU

The definition and classification of the dystonias: A new consensus report

Updates include additional clinical features, clarifications, emphasis on the extensive underlying biological heterogeneity across subtypes.

www.movementdisorders.org

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 10d

#MDSCongress experts will review the most impactful recent publications in both clinical and basic neuroscience. Mdscongress.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 11d

New study shows deep learning can classify tremors from hand-drawn spirals. https://loom.ly/xRbdldE

Deep learning-based artificial intelligence algorithm to classify tremors from hand-drawn spirals

Study affirms that hand-drawn spirals contain quantifiable features that can be leveraged by DL models.

www.movementdisorders.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 11d

New Moving Along issue: 40 years of MDS, dystonia classification, MDSgene updates, and more.
Read all the latest: https://loom.ly/tHQICZU

Moving Along 2025, issue 3

40 years of MDS: A look back through the newsletter

www.movementdisorders.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 12d

Did you know Movement Disorders the first-ever video journal? Discover how this innovation helped establish consensus, and the field itself.

Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 12d

Junior Awardee Dr. Jung Hwan Shin discusses his journey through movement disorders and what led him to study specific neuronal sub-types within the STN. He shares his future hopes for DBS treatments and how he believes his research may contribute. https://loom.ly/2xVAI74

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 12d

Junior Awardee Dr. Lydia Chougar discusses her work combining neuroimaging with transcriptomics and PET maps to uncover the biological underpinnings of structural abnormalities in multiple system atrophy. https://loom.ly/SaQGrvM

1 1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 13d

Gain the specialty skills to recognize hallmark clinical features, uncover diagnostic clues, and manage a variety of patients. https://loom.ly/NdaHSqA

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 16d

2025 #MDSCongress controversy debates: Learn how to make a more informed choice when sharing research results with patients and how a biologically-based definition of PD may or may not accelerate therapeutic discovery. Mdscongress.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 17d

Visual examples are incredibly helpful for learning the different functional movement disorders and their mechanisms. This course uses patient videos to demonstrate how clinicians evaluate often-tricky diagnoses. https://loom.ly/axmgg-4

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 18d

Celebrating 40 Years of MDS — and the Women Who Paved the Way

As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org

3

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 19d

Infection can be the cause of any of the most prevalent movement disorder phenotypes (as shown). A survey of clinicians by the MDS IRMD Study Group indicated that knowledge of the more well-established associations prominently contributes to diagnosis. https://loom.ly/QaddO5I

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 19d

Dr. Cecilia Tremblay discusses her recent study, which is this year's MDCP Research Article of the Year, highlighting the potential accuracy of hyposmia and RBD in predicting Lewy pathology. https://loom.ly/x-625g4

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 19d

Dr. Charulata Sankhla discusses the main findings of this year's MDCP Review Article of the Year, which covers the current status and diagnosis of subacute sclerosing panencephalitis (SSPE). https://loom.ly/uafZc2g

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 20d

Attend the Video Challenge, MDS’s most popular event, at the #MDSCongress. Register today. mdscongress.org

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 23d

MDS is planning for 2026, and your feedback is important. Help guide the future of our educational offerings. https://loom.ly/qSx50w8

MDS-0725-434: MDS Education Needs Assessment 2026

Take this survey powered by surveymonkey.com. Create your own surveys for free.

www.surveymonkey.com

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 24d

International collaboration has helped advance our understanding of movement disorders. Learn about global successes and strategies to address current gaps in global access to research and care. Mdscongress.org

1

International Parkinson and Movement Disorder Society® @movedisorder.bsky.social · 25d

This year’s #mdscongress theme celebrates the future of disease-modifying therapies and the many areas of investigation designated to achieving this goal within the field of PD.